Momenta Pharmaceuticals Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Momenta Pharmaceuticals Inc.

An SI Board Since March 2004

Posts	SubjectMarks	Bans	Symbol
3027	64	0	MNTA

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1127	Maybe they've listened once too often to Cramer ranting about UPOD ... Unde	Ian@SI	-	5/8/2007
1126	MS conference is very good. Much better than hearing the same stale presentation	rkrw	-	5/8/2007
1125	Edited to add June - misread the screen the first time: Lots of May & June	IRWIN JAMES FRANKEL	-	5/7/2007
1124	Consider what every day of sales is worth as a first to market generic. $2M in s	rkrw	-	5/7/2007
1123	VP of MNTA on the cover of the business section of the Boston Globe. boston.com	Go Market Go!	-	5/7/2007
1122	MNTA still on the Reg SHO list as is DNDN. ij	IRWIN JAMES FRANKEL	-	5/7/2007
1121	I have always liked the MS unplugged conference. But truth be told these CEO ca	kenhott	-	5/7/2007
1120	To avoid a serious futility argument by MNTA, Amphastar has to say is they are w	IRWIN JAMES FRANKEL	-	5/7/2007
1119	I think futility is possible but how long would that take? May be cheaper to set	rkrw	-	5/7/2007
1118	As rkrw and ij said, the question is whether the <i>futility</i> arg	DewDiligence_on_SI	-	5/6/2007
1117	As usual rkrw covered all the bases. :-) >>* apparently there's a wa	IRWIN JAMES FRANKEL	-	5/6/2007
1116	ij<<<Putting on my economics hat - that says that the cost and timing a	IRWIN JAMES FRANKEL	-	5/6/2007
1115	First to file does control the 6 month exclusivity. It's a major loophole in	rkrw	-	5/6/2007
1114	<i>Who is entitled to 180-day exclusivity when this happens?</i> I	Biomaven	-	5/6/2007
1113	<<<Putting on my economics hat - that says that the cost and timing adv	rkrw	-	5/6/2007
1112	<i>there is precedent for a later-filed ANDA being granted first</i>	DewDiligence_on_SI	-	5/6/2007
1111	The MS presentation was entirely Q&A. Mostly the same stuff. There were a	IRWIN JAMES FRANKEL	-	5/6/2007
1110	Long was Halozyme. Other shorts were Renovis, Neopharm, and this year Neurochem.	Biomaven	-	5/4/2007
1109	AGIX was one of Aschoff's shorts - what was the other? And the long? The U	Robohogs	-	5/3/2007
1108	<i>Analysts in general are fearful of going out on a limb and looking bad.	DewDiligence_on_SI	-	5/3/2007
1107	Option IV bumping up on the large range of the past couple of days. May 15 cal	tuck	-	5/3/2007
1106	Another short raid - dumped 70K shares in 3 minutes taking the stock down 50 cen	IRWIN JAMES FRANKEL	-	5/3/2007
1105	The DNDN situation has been interesting to watch. Even after the good news came	IRWIN JAMES FRANKEL	-	5/3/2007
1104	DB has been favorable all along, but what to say now other than wait? Cowen has	rkrw	-	5/3/2007
1103	OK, no new rumor. Thanks.	scaram(o)uche	-	5/3/2007

Go to reply# or date (mm/dd/yy):